Ethics of antibiotic allergy

Area of Science:

• Medical Ethics
• Infectious Diseases
• Clinical Pharmacology

Background:

• Antibiotic allergies are frequently reported but often unsubstantiated upon re-exposure.
• Inaccurate penicillin allergy labels complicate treatment for serious infections, leading to the use of less effective antibiotics.
• This reliance on second-line drugs poses significant public health and ethical challenges.

Purpose of the Study:

• To ethically analyze the dilemma of managing infections in patients with reported antibiotic allergies.
• To evaluate the benefit-risk ratio of using first-line versus second-line antibiotics in such cases.
• To propose improvements in policy, research, and education regarding antibiotic allergy management.

Main Methods:

• Empirically informed ethical analysis.
• Case study: *Staphylococcus aureus* bacteraemia in patients with penicillin allergies.
• Review of clinical practice, allergy testing limitations, and ethical considerations.

Main Results:

• Most reported antibiotic allergies are not clinically significant upon re-challenge.
• Using first-line penicillin-based antibiotics may offer a more favorable benefit-risk profile than second-line alternatives.
• Current clinical practices and allergy testing strategies have limitations in acute settings.

Conclusions:

• Prescribing first-line penicillin antibiotics to patients with reported allergies can be ethically justifiable and clinically advantageous.
• Revising policies, research, and medical education is crucial for improving antibiotic allergy management.
• Challenging inaccurate allergy labels can optimize patient care and public health outcomes.